A detailed history of Assenagon Asset Management S.A. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 2,149,937 shares of MRK stock, worth $211 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
2,149,937
Previous 1,344,366 59.92%
Holding current value
$211 Million
Previous $166 Million 46.69%
% of portfolio
0.51%
Previous 0.42%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$111.15 - $128.97 $89.5 Million - $104 Million
805,571 Added 59.92%
2,149,937 $244 Million
Q2 2024

Jul 18, 2024

SELL
$123.8 - $132.96 $36 Million - $38.6 Million
-290,538 Reduced 17.77%
1,344,366 $166 Million
Q1 2024

Apr 24, 2024

BUY
$113.24 - $131.95 $53.2 Million - $62 Million
470,217 Added 40.37%
1,634,904 $216 Million
Q4 2023

Jan 17, 2024

SELL
$100.18 - $109.02 $18.2 Million - $19.8 Million
-181,345 Reduced 13.47%
1,164,687 $127 Million
Q3 2023

Nov 06, 2023

BUY
$102.95 - $114.33 $84.1 Million - $93.4 Million
817,128 Added 154.49%
1,346,032 $139 Million
Q2 2023

Jul 25, 2023

SELL
$108.61 - $118.38 $133 Million - $145 Million
-1,227,869 Reduced 69.89%
528,904 $61 Million
Q1 2023

Apr 18, 2023

BUY
$102.94 - $114.86 $26.6 Million - $29.6 Million
257,964 Added 17.21%
1,756,773 $187 Million
Q4 2022

Jan 12, 2023

SELL
$87.44 - $112.11 $100 Million - $129 Million
-1,148,321 Reduced 43.38%
1,498,809 $166 Million
Q3 2022

Oct 27, 2022

BUY
$84.53 - $94.96 $161 Million - $181 Million
1,901,328 Added 254.94%
2,647,130 $228 Million
Q2 2022

Jul 27, 2022

SELL
$83.49 - $94.64 $27.3 Million - $30.9 Million
-326,773 Reduced 30.47%
745,802 $68 Million
Q1 2022

Apr 25, 2022

BUY
$73.51 - $82.4 $75.2 Million - $84.3 Million
1,022,576 Added 2045.19%
1,072,575 $88 Million
Q4 2021

Feb 01, 2022

BUY
$72.28 - $90.54 $270,399 - $338,710
3,741 Added 8.09%
49,999 $3.83 Million
Q3 2021

Oct 19, 2021

BUY
$71.68 - $78.83 $1.76 Million - $1.94 Million
24,553 Added 113.12%
46,258 $3.47 Million
Q2 2021

Jul 15, 2021

BUY
$70.31 - $77.77 $149,549 - $165,416
2,127 Added 10.86%
21,705 $1.69 Million
Q1 2021

Apr 26, 2021

BUY
$68.86 - $81.11 $80,772 - $95,142
1,173 Added 6.37%
19,578 $1.51 Million
Q4 2020

Feb 01, 2021

BUY
$71.77 - $79.65 $421,289 - $467,545
5,870 Added 46.83%
18,405 $1.44 Million
Q3 2020

Oct 07, 2020

BUY
$73.18 - $82.95 $110,794 - $125,586
1,514 Added 13.74%
12,535 $1.04 Million
Q2 2020

Jul 21, 2020

SELL
$70.42 - $80.13 $3.05 Million - $3.47 Million
-43,301 Reduced 79.71%
11,021 $852,000
Q1 2020

Apr 17, 2020

SELL
$63.36 - $87.82 $128 Million - $178 Million
-2,027,752 Reduced 97.39%
54,322 $4.18 Million
Q4 2019

Jan 17, 2020

BUY
$77.58 - $87.54 $99.3 Million - $112 Million
1,279,670 Added 159.48%
2,082,074 $189 Million
Q3 2019

Oct 16, 2019

BUY
$76.08 - $82.93 $3.28 Million - $3.58 Million
43,140 Added 5.68%
802,404 $67.5 Million
Q2 2019

Aug 12, 2019

BUY
$69.84 - $81.59 $52.1 Million - $60.9 Million
746,564 Added 5878.46%
759,264 $63.7 Million
Q1 2019

Apr 26, 2019

SELL
$69.58 - $79.36 $76,538 - $87,296
-1,100 Reduced 7.97%
12,700 $1.06 Million
Q4 2018

Jan 23, 2019

SELL
$65.24 - $75.71 $71.6 Million - $83 Million
-1,096,935 Reduced 98.76%
13,800 $1.05 Million
Q3 2018

Oct 29, 2018

BUY
$57.69 - $67.84 $50.2 Million - $59 Million
870,423 Added 362.21%
1,110,735 $78.8 Million
Q2 2018

Jul 17, 2018

BUY
$50.83 - $59.72 $12.2 Million - $14.4 Million
240,312 New
240,312 $14.6 Million
Q4 2017

Jan 25, 2018

SELL
$51.62 - $61.64 $37.7 Million - $45 Million
-729,590 Closed
0 $0
Q3 2017

Oct 18, 2017

BUY
$58.67 - $63.13 $42.8 Million - $46.1 Million
729,590
729,590 $46.7 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.